Mercado global de adesivos transdérmicos – Tendências do setor e previsão para 2031

Análise e dimensão do mercado de adesivos transdérmicos

No mercado dos adesivos transdérmicos na esfera médica, estes adesivos introduzem uma abordagem transformadora à administração de medicamentos, alavancando o conceito de administração transdérmica. Aderindo à pele, facilitam a libertação controlada de medicamentos diretamente na corrente sanguínea, oferecendo um alívio sustentado e efeitos secundários minimizados. Amplamente utilizados no tratamento da dor, na terapia de substituição hormonal e na terapia de substituição da nicotina, os adesivos transdérmicos proporcionam uma alternativa discreta e conveniente aos medicamentos orais tradicionais. A sua eficácia estende-se à prevenção do enjoo, ao tratamento de distúrbios neurológicos e ao atendimento de diversas necessidades terapêuticas, marcando um avanço significativo nos tratamentos médicos transdérmicos.

O tamanho global do mercado de adesivos transdérmicos foi avaliado em 7,48 mil milhões de dólares em 2023 e deverá atingir os 10,97 mil milhões de dólares até 2031, com um CAGR de 4,9% durante o período de previsão de 2024 a 2031. Além dos insights sobre cenários de mercado, como o valor do mercado, a taxa de crescimento, a segmentação, a cobertura geográfica e os grandes players, os relatórios de mercado com curadoria da Data Bridge Market Research incluem também análises especializadas aprofundadas, epidemiologia dos doentes, análise de pipeline, análise de preços e a estrutura regulatória.

Âmbito do relatório e segmentação de mercado       

Market Definition

Transdermal patches are adhesive patches applied to the skin to deliver medication through the skin and into the bloodstream over time. They provide a convenient and controlled way of administering drugs, bypassing the digestive system and offering continuous release for sustained therapeutic effects.

Transdermal Patches Market Dynamics

Drivers                                                                                          

• Rising Smoker Population results in Increased Demand for Transdermal Patches

The region's growing smoking population, as evidenced by the CDC's data indicating high usage rates among both high school and middle school students, underscores the escalating demand for smoking cessation aids like nicotine transdermal patches. With approximately 34.0% of high school students and 11.3% of middle school students having used tobacco products, including cigarettes, e-cigarettes, and other variants, there's a pressing need for effective strategies to combat nicotine addiction. Transdermal patches offer a viable solution, providing a discreet and gradual method for delivering nicotine replacement therapy. This surge in demand fueled by the youth demographic contributes significantly to the expansion of the transdermal patches market in the region.

• Increased Prevalence of Cancer Propels the Adoption of Transdermal Patches

The escalating incidence of breast and prostate cancer, as highlighted by reports like GLOBOCAN 2020, notably accelerates the growth trajectory of the transdermal patches market. With Mexico alone projecting a substantial increase in cancer cases over the coming decades, reaching 254,665 new cases by 2030 and 323,432 by 2040, and the demand for innovative drug delivery systems intensifies. Transdermal patches, particularly those containing medication nanoparticles tailored for cancer therapy-related pain management, stand poised to address this growing need. Their non-invasive nature and ability to provide controlled release make them an attractive option for patients grappling with pain associated with cancer treatments, further solidifying their role as a vital component in oncology care, specifically in the domain of transdermal patches for pain.

Opportunities

• Technological Advancements Propel Transdermal Patches to New Levels of Versatility

Innovations in patch design, materials, and drug delivery mechanisms continually enhance the efficacy, safety, and versatility of transdermal patches. These advancements enable the delivery of a broader range of drugs, including those with challenging physicochemical properties, expanding the market's scope across various therapeutic areas. Advancements in manufacturing processes improve scalability and reduce production costs, making transdermal patches more accessible to patients and healthcare providers. As technology evolves, it drives the development of novel patch-based delivery systems, stimulating market expansion and fostering a competitive landscape driven by innovation.

• Rising Healthcare Facility Investments lead to the Adoption of Transdermal Patches

With greater investment, healthcare facilities can afford to adopt and promote innovative drug delivery systems like transdermal patches. These investments enable facilities to enhance their infrastructure, procure advanced medical technologies, and expand their range of treatment options. As healthcare providers strive to improve patient care and outcomes, they increasingly embrace transdermal patches for their convenience and efficacy through improved medication adherence and management of chronic conditions. This growing investment creates a conducive environment for the widespread adoption and utilization of transdermal patches in various healthcare settings, thereby driving market expansion.

Restraints/Challenges

• High Product Cost Limits the Adoption of Transdermal Patches

Compared to conventional oral medications, transdermal patches often entail higher manufacturing expenses due to specialized formulation requirements and the need for precise drug delivery systems. The production of patches with advanced features, such as controlled-release mechanisms, can further increase production costs. These higher manufacturing costs may translate into elevated prices for consumers, potentially limiting their affordability and accessibility, particularly in healthcare systems with budget constraints. Consequently, addressing cost concerns is crucial for ensuring widespread adoption and equitable access to transdermal patches as a viable drug delivery option.

• Skin Irritation Affecting Patient Comfort Limits Transdermal Delivery Systems

Adhesive components or drug formulations in patches may trigger allergic reactions or irritate sensitive skin, limiting their use in specific individuals. This issue necessitates careful consideration of patch materials and formulations to minimize adverse skin reactions. Moreover, skin irritation can lead to discontinuation of treatment and loss of patient confidence in transdermal delivery systems.

This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Developments

• In 2022, Adlarity, developed by Corium, debuted in the U.S. as a prescription medication. This once-weekly transdermal patch delivers consistent doses of donepezil, offering a convenient treatment option for patients with mild, moderate, or severe Alzheimer’s-related dementia. Its innovative delivery system aims to enhance patient compliance and improve therapeutic outcomes
• In 2022, the Luye Pharma Group received approval from China's National Medical Products Administration for their Rivastigmine Twice Weekly Transdermal Patch. This patch, designed for mild to moderate Alzheimer's symptoms, offers a convenient dosing schedule and aims to improve patient adherence. With its innovative transdermal delivery method, it represents a promising addition to Alzheimer's disease management in China

Transdermal Patches Market Scope

The market is segmented on the basis of product, type, application, technology, distribution channel, and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Single-Layer Drug-In-Adhesive
• Multi-Layer Drug-In-Adhesive
• Matrix
• Reservoir
• Vapor
• Others

Type

• Fentanyl Transdermal Patch
• Nicotine Transdermal Patch
• Buprenorphine Transdermal Patch
• Clonidine Transdermal Patch
• Oxybutynin Transdermal Patch
• Others

Application

• Cardiovascular Disorder
• Central Nervous System Disorders (CNS)
• Pain Management/ Relief
• Smoking Reduction and Cessation Aid
• Overactive Bladder
• Nicotine Cessation
• Hormonal Therapy/ Disorders
• Dermatology
• Others

Technology

• Electric Current
• Mechanical Arrays
• Thermal Ablation
• Chemical Enhancers
• Others

Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

End User

• Home Care settings
• Hospitals
• Clinics

Transdermal Patches Market Regional Analysis/Insights

The market is analysed and market size insights and trends are provided by country, product, type, application, technology, distribution channel, and end user as referenced above.

The countries covered in the market report are U.S., Canada, Mexico, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, rest of Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, rest of Middle East and Africa, Brazil, Argentina and rest of South America.

Prevê-se que a América do Norte domine o mercado devido à região possuir uma rede robusta de instalações de saúde, facilitando o acesso generalizado ao tratamento. Os principais players da indústria farmacêutica estabeleceram uma presença significativa na América do Norte, impulsionando a inovação e a distribuição. Além disso, o compromisso da região com a investigação e o desenvolvimento na área da saúde alimenta avanços contínuos, solidificando ainda mais o seu domínio no mercado. Estes factores contribuem colectivamente para a fortaleza da América do Norte no panorama farmacêutico.

Prevê-se que a Ásia-Pacífico tenha um crescimento substancial, impulsionado por vários factores. As iniciativas governamentais que promovem a sensibilização para os cuidados de saúde, juntamente com a expansão das infra-estruturas de saúde, irão catalisar este crescimento. O aumento das actividades de investigação contribui ainda mais para alcançar os vastos mercados desconhecidos e a grande base populacional da região. Além disso, a crescente procura de serviços de saúde de qualidade sublinha o potencial da região como um interveniente crítico no panorama global dos cuidados de saúde.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.

Base instalada de crescimento da infraestrutura de saúde e penetração de novas tecnologias

O mercado também fornece análises de mercado detalhadas para o crescimento de cada país em despesas de saúde para equipamentos de capital, base instalada de diferentes tipos de produtos para o mercado, impacto da tecnologia utilizando curvas de linha de vida e mudanças nos cenários regulamentares de saúde e o seu impacto no mercado. Os dados estão disponíveis para o período histórico 2016-2021.

Análise do panorama competitivo e do mercado dos adesivos transdérmicos

O cenário competitivo do mercado fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas em relação ao mercado.

Alguns dos principais players que operam no mercado são:

• AdhexPharma (França)
• ProSolus, Inc (EUA)
• tesa SE (Alemanha)
• Corporação Nitto Denko. (Japão)
• Noven Pharmaceuticals, Inc (EUA)
• LTS Lohmann Therapie-Systeme AG (Alemanha)
• Medherant Limited (Reino Unido)
• Corium, Lda. (NÓS)
• Bayer AG (Alemanha)
• Novartis AG (Suíça)
• Antares Pharma (EUA)
• Abade. (NÓS)
• Mylan NV (EUA)
• Acrux Limited (Austrália)
• Sparsha Pharma International Pvt Ltd (Índia)
• Bliss GVS Pharma. (Índia)
• (EUA)
• Informa Connect Limited (Reino Unido)

SKU-28669